132 related articles for article (PubMed ID: 21419756)
1. Autotaxin as a novel serum marker of liver fibrosis.
Nakagawa H; Ikeda H; Nakamura K; Ohkawa R; Masuzaki R; Tateishi R; Yoshida H; Watanabe N; Tejima K; Kume Y; Iwai T; Suzuki A; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Omata M; Igarashi K; Aoki J; Koike K; Yatomi Y
Clin Chim Acta; 2011 Jun; 412(13-14):1201-6. PubMed ID: 21419756
[TBL] [Abstract][Full Text] [Related]
2. [Significance of serum autotaxin activity in gastrointestinal disease].
Ikeda H; Watanabe N; Nakamura K; Kume Y; Nakai Y; Fujishiro M; Omata M; Igarashi K; Yokota H; Yatomi Y
Rinsho Byori; 2009 May; 57(5):445-9. PubMed ID: 19522250
[TBL] [Abstract][Full Text] [Related]
3. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
[TBL] [Abstract][Full Text] [Related]
4. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma.
Masuda A; Nakamura K; Izutsu K; Igarashi K; Ohkawa R; Jona M; Higashi K; Yokota H; Okudaira S; Kishimoto T; Watanabe T; Koike Y; Ikeda H; Kozai Y; Kurokawa M; Aoki J; Yatomi Y
Br J Haematol; 2008 Oct; 143(1):60-70. PubMed ID: 18710386
[TBL] [Abstract][Full Text] [Related]
5. Specific increase in serum autotaxin activity in patients with pancreatic cancer.
Nakai Y; Ikeda H; Nakamura K; Kume Y; Fujishiro M; Sasahira N; Hirano K; Isayama H; Tada M; Kawabe T; Komatsu Y; Omata M; Aoki J; Koike K; Yatomi Y
Clin Biochem; 2011 Jun; 44(8-9):576-81. PubMed ID: 21439952
[TBL] [Abstract][Full Text] [Related]
6. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation.
Nakamura K; Igarashi K; Ide K; Ohkawa R; Okubo S; Yokota H; Masuda A; Oshima N; Takeuchi T; Nangaku M; Okudaira S; Arai H; Ikeda H; Aoki J; Yatomi Y
Clin Chim Acta; 2008 Feb; 388(1-2):51-8. PubMed ID: 17963703
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
8. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
[TBL] [Abstract][Full Text] [Related]
9. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
10. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
12. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.
Wong GL; Wong VW; Choi PC; Chan AW; Chan HL
Aliment Pharmacol Ther; 2010 May; 31(10):1095-103. PubMed ID: 20180785
[TBL] [Abstract][Full Text] [Related]
13. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
14. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
[TBL] [Abstract][Full Text] [Related]
15. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
Shin WG; Park SH; Jang MK; Hahn TH; Kim JB; Lee MS; Kim DJ; Jun SY; Park CK
Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
17. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
[TBL] [Abstract][Full Text] [Related]
18. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
19. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
20. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
